U.S. Rep. Dina Titus, D-Nev., led a bipartisan quartet of House members who sent the president and three of his cabinet members a letter on Aug. 18 asking for greater clarity in the federal policy that moved medical cannabis and FDA-approved cannabis products under Schedule III of the Controlled Substances Act (CSA). The letter was also addressed to Attorney General Todd Blanche, who signed the Schedule III order on April 23, Health Secretary Robert Kennedy Jr.
and Treasury Secretary Scott Bessent.
Reps. Dave Joyce, R-Ohio, Ilhan Omar, D-Minn., and Greg Steube, R-Fla., also signed the letter. The group noted that the recent order marks a significant step in establishing a federal framework for state-licensed medical marijuana entities. They stated that they appreciate this development and the progress it reflects toward greater clarity in federal policy.
The letter specifically requested guidance on practical questions including worker protections, patient rights, and health care coverage. It also asked for details on privacy safeguards, home cultivation, and the operation of the new DEA registration system. The lawmakers emphasized the need for consistent information to provide to their constituents.
“The order marks a significant step in establishing a federal framework for certain state-licensed medical marijuana entities to register and comply with the CSA,” the lawmakers wrote. “We appreciate this development and the progress it reflects toward greater clarity in federal policy.”
“As implementation moves forward, additional guidance would be helpful on several practical questions, including worker protections, patient rights, health care coverage, privacy safeguards, home cultivation and the operation of the new DEA registration system,” the lawmakers wrote. The administration has not yet responded to the specific questions raised in the Aug.
The House members said they looked forward to the White House officials’ continued efforts to advance clear and effective cannabis policy.
Lawsuit Filed Over Facility Odor Residents of Rock Hill are suing Proper Brands, arguing that a "skunky" smell from the…
Expert Warning On Outdated Testing Dr Georges Petitjean has warned that workplace drug testing has failed to keep pace with…
Event Details Shore House Canna, an adult-use dispensary in West Cape May, New Jersey, will host its 3rd Annual Fall…
Sabalenka Stops Play Over Cannabis Smell Top seed Aryna Sabalenka briefly halted her US Open third-round match against Kamilla Rakhimova…
CBDD Signs Definitive Agreement to Acquire BioCannabis CBD of Denver, Inc. (OTCID: CBDD) announced on September 15, 2026 that it…
Seventh Annual New Jersey Cannabis Convention Set NECANN brings the New Jersey Cannabis Convention back to the Atlantic City Convention…
